No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
LADX LadRx
- 1.967500
- +0.467500+31.17%
15min DelayClose Dec 13 16:00 ET
974.09KMarket Cap-0.34P/E (TTM)
1.990000High1.640000Low4.67KVolume1.890000Open1.500000Pre Close8.91KTurnover0.95%Turnover Ratio2.89P/E (Static)495.09KShares3.50000052wk High-0.56P/B962.41KFloat Cap0.46210052wk Low--Dividend TTM489.16KShs Float162225.000000Historical High--Div YieldTTM23.33%Amplitude0.462100Historical Low1.909000Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
LadRx LADX +236% 505(b)(2) Process; Keros KROS -73% Voluntary Halt
LadRx Planning NDA Submission Under 505(b)(2) for Aldoxorubicin and Other Updates
LadRx | 10-Q: Q3 2024 Earnings Report
LadRx: Q2 Earnings Snapshot
LadRx | 10-Q: Q2 2024 Earnings Report
ImmunityBio, LadRx End Licensing Deal for Cancer Drug
Heat List
US
Overall
Symbol
Price
% Chg
No Data
